Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Spencer

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Harvard Review of Psychiatry|April 27, 2010
Gamma oscillation deficits and the onset and early progression of schizophreniaTsung-Ung W Woo, Kevin Spencer, Robert W McCarley
Prenatal Diagnosis|November 15, 2013
First trimester maternal serum alpha-fetoprotein is not raised in pregnancies with open spina bifidaKevin Spencer, Asma Khalil, Louise Brown, et al.
Prenatal Diagnosis|April 2, 2004
The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancyKevin Spencer, Renu Bindra, Anna Maria Cacho, et al.
Clinical Chemistry and Laboratory Medicine|February 18, 2016
A technical and clinical evaluation of a new assay for inhibin A and its use in second trimester Down syndrome screeningGeorgina Wilson, Päivi Liitti, Tuukka Pölönen, et al.
Prenatal Diagnosis|March 18, 2011
Screening in the presence of a vanished twin: nuchal translucency or combined screening test?Srividhya Sankaran, Claire Rozette, Judith Dean, et al.
Prenatal Diagnosis|February 5, 2011
The stability of free-β human chorionic gonadotrophin and pregnancy-associated plasma protein-A in first trimester dried blood spotsNicholas J Cowans, Anastasia Stamatopoulou, Paivi Liitti, et al.
Prenatal Diagnosis|April 4, 2003
Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeksSimona Cicero, Renu Bindra, Georgios Rembouskos, et al.
Prenatal Diagnosis|October 26, 2005
Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screeningSimona Cicero, Kevin Spencer, Kyriaki Avgidou, et al.
Clinical Chemistry|February 22, 2013
Evaluation of a dried blood spot assay to measure prenatal screening markers pregnancy-associated plasma protein a and free β-subunit of human chorionic gonadotropinNicholas J Cowans, Mikko Suonpaa, Heikki Kouru, et al.
Journal of Educational Evaluation for Health Professions|April 16, 2019
Development and Validation of the Hocus Focus Magic Performance Evaluation Scale for Health Professions Personnel in the United StatesKevin Spencer, Hon Keung Yuen, Max Darwin, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Harvard Review of Psychiatry|April 27, 2010
Gamma oscillation deficits and the onset and early progression of schizophreniaTsung-Ung W Woo, Kevin Spencer, Robert W McCarley
Prenatal Diagnosis|November 15, 2013
First trimester maternal serum alpha-fetoprotein is not raised in pregnancies with open spina bifidaKevin Spencer, Asma Khalil, Louise Brown, et al.
Prenatal Diagnosis|April 2, 2004
The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancyKevin Spencer, Renu Bindra, Anna Maria Cacho, et al.
Clinical Chemistry and Laboratory Medicine|February 18, 2016
A technical and clinical evaluation of a new assay for inhibin A and its use in second trimester Down syndrome screeningGeorgina Wilson, Päivi Liitti, Tuukka Pölönen, et al.
Prenatal Diagnosis|March 18, 2011
Screening in the presence of a vanished twin: nuchal translucency or combined screening test?Srividhya Sankaran, Claire Rozette, Judith Dean, et al.
Prenatal Diagnosis|February 5, 2011
The stability of free-β human chorionic gonadotrophin and pregnancy-associated plasma protein-A in first trimester dried blood spotsNicholas J Cowans, Anastasia Stamatopoulou, Paivi Liitti, et al.
Prenatal Diagnosis|April 4, 2003
Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeksSimona Cicero, Renu Bindra, Georgios Rembouskos, et al.
Prenatal Diagnosis|October 26, 2005
Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screeningSimona Cicero, Kevin Spencer, Kyriaki Avgidou, et al.
Clinical Chemistry|February 22, 2013
Evaluation of a dried blood spot assay to measure prenatal screening markers pregnancy-associated plasma protein a and free β-subunit of human chorionic gonadotropinNicholas J Cowans, Mikko Suonpaa, Heikki Kouru, et al.
Journal of Educational Evaluation for Health Professions|April 16, 2019
Development and Validation of the Hocus Focus Magic Performance Evaluation Scale for Health Professions Personnel in the United StatesKevin Spencer, Hon Keung Yuen, Max Darwin, et al.
Pageof 10